Oncotarget

Corrections:

Correction: Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle

Francesca Pretto, Carmen Ghilardi, Michele Moschetta, Andrea Bassi, Alessandra Rovida, Valentina Scarlato, Laura Talamini, Fabio Fiordaliso, Cinzia Bisighini, Giovanna Damia, Maria Rosa Bani, Rosanna Piccirillo and Raffaella Giavazzi _

PDF  |  How to cite

Oncotarget. 2016; 7:38973. https://doi.org/10.18632/oncotarget.9971

Metrics: PDF 3118 views  |   ?  

Present: Due to an error made during the manuscript revision process, a notice designating Drs. Rosanna Piccirillo and Raffaella Giavazzi as joint last authors has been omitted.

Corrected: Correct author list is provided below. Authors sincerely apologize for this oversight.

Original article: Oncotarget. 2015; 6(5): 3043-54. DOI: 10.18632/oncotarget.2812

Francesca Pretto1,4,*, Carmen Ghilardi1,*, Michele Moschetta1, Andrea Bassi2, Alessandra Rovida1, Valentina Scarlato1, Laura Talamini1, Fabio Fiordaliso3, Cinzia Bisighini3, Giovanna Damia1, Maria Rosa Bani1, Rosanna Piccirillo1,** and Raffaella Giavazzi1,**

1 Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche “Mario Negri”, 20156 Milan, Italy
2 Department of Phisics, Politecnico di Milano, 20133 Milan, Italy3 Department of Cardiovascular Research, IRCCS-Istituto di Ricerche Farmacologiche “Mario Negri”, 20156 Milan, Italy 4 Present address: Philochem AG, 8112 Otelfingen, Switzerland
*These authors have contributed equally to this work
** Joint last authors


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9971